Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
17.43
+0.39 (2.29%)
At close: May 14, 2026, 4:00 PM EDT
17.93
+0.50 (2.87%)
Pre-market: May 15, 2026, 7:13 AM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.8 billion as of May 15, 2026. Its market cap has increased by 62.72% in one year.
Market Cap
1.80B
Enterprise Value
1.09B
1-Year Change
62.72%
Ranking
Category
Stock Price
$17.43
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.80B, an increase of 5,077.50%. That is a compound annual growth rate of 39.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 1.80B | -39.51% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 1.81B |
| Rapport Therapeutics | 1.81B |
| Palvella Therapeutics | 1.79B |
| Harmony Biosciences Holdings | 1.76B |
| Zymeworks | 1.74B |
| MBX Biosciences | 1.74B |
| Vericel | 1.69B |
| Agios Pharmaceuticals | 1.68B |